MedPath
TGA Approval

Norpace Retard (Disopyramide Base 150mg) Tablets (32754)

32754

Norpace Retard (Disopyramide Base 150mg) Tablets

Proqualix Pty Ltd - in Administration

October 28, 1991

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

disopyramide phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norpace Retard (Disopyramide Base 150mg) Tablets (32754) - TGA 批准文号 | MedPath